MEDI 452-Discovery of nicotinamides and related derivatives as potent and selective NCX reverse mode inhibitors

被引:0
|
作者
Kakefuda, Akio [1 ]
Kuramochi, Takahiro [1 ]
Yamada, Hiroyoshi [1 ]
Sato, Ippei [1 ]
Tsukamoto, Issei [1 ]
Taguchi, Taku [2 ]
Sakamoto, Shuichi [3 ]
机构
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
[2] Astellas Pharma Inc, QA, RA & Pharmacovigilance, Itabashi Ku, Tokyo 1748612, Japan
[3] Astellas Pharma Inc, Technol, Itabashi Ku, Tokyo 1748612, Japan
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
452-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
    Tabrizi, Mojgan Aghazadeh
    Baraldi, Pier Giovanni
    Baraldi, Stefania
    Ruggiero, Emanuela
    De Stefano, Lucia
    Rizzolio, Flavio
    Mannelli, Lorenzo Di Cesare
    Ghelardini, Carla
    Chicca, Andrea
    Lapillo, Margherita
    Gertsch, Jurg
    Manera, Clementina
    Macchia, Marco
    Martinelli, Adriano
    Granchi, Carlotta
    Minutolo, Filippo
    Tuccinardi, Tiziano
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 1340 - 1354
  • [42] Discovery of C-5 Pyrazole-Substituted Pyrrolopyridine Derivatives as Potent and Selective Inhibitors for Janus Kinase 1
    Lang, Jia-Jia
    Lv, You
    Kobe, Bostjan
    Chen, Hongfei
    Tan, Yan
    Chen, Limei
    Wang, Xuechuan
    Mi, Pengbing
    Zheng, Xing
    Lin, Ying-Wu
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (10) : 6725 - 6742
  • [43] Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors
    Ding, Xiao
    Dai, Xuedong
    Long, Kai
    Peng, Cheng
    Andreotti, Daniele
    Bamborough, Paul
    Eatherton, Andrew J.
    Edge, Colin
    Jandu, Karamjit S.
    Nichols, Paula L.
    Philps, Oliver J.
    Stasi, Luigi Piero
    Wan, Zehong
    Xiang, Jia-Ning
    Dong, Kelly
    Dossang, Pamela
    Ho, Ming-Hsun
    Li, Yi
    Mensah, Lucy
    Guan, Xiaoming
    Reith, Alastair D.
    Ren, Feng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (17) : 4034 - 4038
  • [44] Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors
    Iwashita, A
    Hattori, K
    Yamamoto, H
    Ishida, J
    Kido, Y
    Kamijo, K
    Murano, K
    Miyake, H
    Kinoshita, T
    Warizaya, M
    Ohkubo, M
    Matsuoka, N
    Mutoh, S
    FEBS LETTERS, 2005, 579 (06) : 1389 - 1393
  • [45] Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase
    Duan, Yunxin
    Cheng, Haodong
    Zhuang, Lili
    Xia, Jiawei
    Xu, Yerong
    Zhang, Ruyue
    Sun, Rui
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 255
  • [46] New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase
    Bellarosa, D
    Antonelli, G
    Bambacioni, F
    Giannotti, D
    Viti, G
    Nannicini, R
    Giachetti, A
    Dianzani, F
    Witvrouw, M
    Pauwels, R
    Desmyter, J
    DeClercq, E
    ANTIVIRAL RESEARCH, 1996, 30 (2-3) : 109 - 124
  • [47] Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability
    Zhao, Li-Min
    Wang, Shuai
    Pannecouque, Christophe
    De Clercq, Erik
    Piao, Hu-Ri
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [48] Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
    Wan, Zheng-Yong
    Yao, Jin
    Tao, Yuan
    Mao, Tian-Qi
    Wang, Xin-Long
    Lu, Yi-Pei
    Wang, Hai-Feng
    Yin, Hong
    Wu, Yan
    Chen, Fen-Er
    De Clercq, Erik
    Daelemans, Dirk
    Pannecouque, Christophe
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 97 : 1 - 9
  • [49] MEDI 51-Discovery and biological evaluation of novel benzamide derivatives as potent 11b-HSD1 inhibitors for the treatment of type II diabetes
    Julian, Lisa D.
    Bostick, Tracy
    Caille, Sebastien
    Chan, Hon
    Degraffenreid, Michael
    He, Xiao
    Hungate, Randall W.
    Jaen, Juan
    Jiang, Ben
    Kaizerman, Jacob
    Liu, Jinsong
    McMinn, Dustin
    Powers, Jay P.
    Rew, Yosup
    Sudom, Athena
    Sun, Daqing
    Tu, Hua
    Ursu, Stefania
    Wang, Zhulun
    Yan, Xuelei
    Ye, Qiuping
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [50] Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors
    Abu Rabah, Reinad R.
    Sebastian, Anusha
    Vunnam, Srinivasulu
    Sultan, Shaista
    Tarazi, Hamadeh
    Anbar, Hanan S.
    Shehata, Mahmoud K.
    Zaraei, Seyed-Omar
    Elgendy, Sara M.
    Al Shamma, Salma A.
    Omar, Hany A.
    Al-Tel, Taleb H.
    El-Gamal, Mohammed, I
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 69